A novel p53-inducible apoptogenic gene,PRG3, encodes a homologue of the apoptosis-inducing factor (AIF) |
| |
Authors: | Ohiro Yoichi Garkavtsev Igor Kobayashi Shinichiro Sreekumar Kodangattil R Nantz Regan Higashikubo Bryan T Duffy Shannon L Higashikubo Ryuji Usheva Anny Gius David Kley Nikolai Horikoshi Nobuo |
| |
Affiliation: | Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. |
| |
Abstract: | The p53 tumor suppressor protein induces cell cycle arrest or apoptosis in response to cellular stresses. We have identified PRG3 (p53-responsive gene 3), which is induced specifically under p53-dependent apoptotic conditions in human colon cancer cells, and encodes a novel polypeptide of 373 amino acids with a predicted molecular mass of 40.5 kDa. PRG3 has significant homology to bacterial oxidoreductases and the apoptosis-inducing factor, AIF, and the gene was assigned to chromosome 10q21.3-q22.1. Expression of PRG3 was induced by the activation of endogenous p53 and it contains a p53-responsive element. Unlike AIF, PRG3 localizes in the cytoplasm and its ectopic expression induces apoptosis. An amino-terminal deletion mutant of PRG3 that lacks a putative oxidoreductase activity retains its apoptotic activity, suggesting that the oxidoreductase activity is dispensable for the apoptotic function of PRG3. The PRG3 gene is thus a novel p53 target gene in a p53-dependent apoptosis pathway. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|